Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-16-010950
Filing Date
2016-02-16
Accepted
2016-02-16 13:12:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 d7039023_sc13g-a1.htm SC 13G/A 114391
  Complete submission text file 0000919574-16-010950.txt   115906
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Subject) CIK: 0001347178 (see all company filings)

EIN.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82196 | Film No.: 161425830
SIC: 2834 Pharmaceutical Preparations

Mailing Address 510 MADISON AVENUE, 22ND FLOOR NEW YORK NY 10022
Business Address 510 MADISON AVENUE, 22ND FLOOR NEW YORK NY 10022 (212) 231-4932
ARMISTICE CAPITAL, LLC (Filed by) CIK: 0001601086 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A